QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
NYSE:SYK

Stryker Price Target, Predictions & Analyst Ratings

$236.63
-6.87 (-2.82%)
(As of 11/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$236.09
$244.90
50-Day Range
$236.63
$276.64
52-Week Range
$220.90
$281.16
Volume
2.67 million shs
Average Volume
1.17 million shs
Market Capitalization
$89.23 billion
P/E Ratio
47.61
Dividend Yield
1.03%
Beta
0.95

Stryker (NYSE:SYK) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 22 Analyst Ratings

Analyst Price Target Consensus

$288.80
22.05% Upside

High PT$320.00
Average PT$288.80
Low PT$252.00
TypeCurrent
11/30/20 to 11/30/21
1 Month Ago
10/31/20 to 10/31/21
3 Months Ago
9/1/20 to 9/1/21
1 Year Ago
12/1/19 to 11/30/20
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
14 Buy rating(s)
14 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
9 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$288.80$288.55$283.86$221.44
Price Target Upside22.05% Upside9.22% Upside9.18% Upside12.23% Upside
Get Stryker Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Stryker (NYSE:SYK) vs. Its Competitors

TypeStrykerMedical CompaniesS&P 500
Consensus Rating Score
2.59
2.72
2.56
Consensus RatingBuyBuyBuy
Price Target Upside22.05% Upside183.06% Upside14.26% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
835
67.83%
Underperform Votes
396
32.17%
Avg. Outperform Votes
176
67.43%
Avg. Underperform Votes
85
32.57%
Avg. Outperform Votes
834
69.44%
Avg. Underperform Votes
367
30.56%

Stryker (NYSE:SYK) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/19/2021Morgan Stanley
Boost Price TargetOverweight$295.00 ➝ $305.00+17.79%
10/29/2021Robert W. Baird
Jeff Johnson
Reiterated RatingBuy$301.00+13.13%
10/29/2021Piper Sandler
Boost Price TargetNeutral$250.00 ➝ $255.00-5.01%
10/22/2021SVB Leerink
D. Antalffy
Reiterated RatingOutperform
9/14/2021Raymond James
Initiated CoverageMarket Perform
7/29/2021Argus
Boost Price TargetBuy$280.00 ➝ $320.00+19.10%
7/28/2021Truist Securities
Boost Price TargetHold$250.00 ➝ $275.00+1.30%
7/28/2021Canaccord Genuity
Boost Price TargetBuy$285.00 ➝ $290.00+6.83%
7/28/2021Credit Suisse Group
Matt Miksic
Boost Price TargetOutperform$291.00 ➝ $311.00+15.89%
7/28/2021Oppenheimer
Boost Price TargetMarket Perform$273.00 ➝ $288.00+7.32%
7/28/2021Northland Securities
UpgradeMarket Perform ➝ Outperform$248.00 ➝ $310.00+15.52%
7/28/2021Needham & Company LLC
Reiterated RatingHold
7/28/2021Citigroup
Boost Price TargetBuy$303.00 ➝ $310.00+15.52%
6/1/2021Evercore ISI
UpgradeIn-Line ➝ Outperform$260.00 ➝ $285.00+11.65%
5/24/2021Barclays
Initiated CoverageUnderweight$280.00+8.89%
4/28/2021Wells Fargo & Company
Boost Price TargetOverweight$265.00 ➝ $300.00+13.19%
4/28/2021Cowen
Boost Price TargetOutperform$255.00 ➝ $279.00+5.27%
4/28/2021Deutsche Bank Aktiengesellschaft
Boost Price TargetBuy$251.00 ➝ $285.00+7.53%
2/24/2021JPMorgan Chase & Co.
Boost Price TargetOverweight$245.00 ➝ $265.00+7.48%
1/4/2021Guggenheim
Initiated CoverageNeutral
12/31/2020BTIG Research
Boost Price TargetBuy$234.00 ➝ $252.00+4.11%
10/30/2020Smith Barney Citigroup
Boost Price Target$232.00 ➝ $240.00+20.29%
9/11/2020Wolfe Research
Initiated CoverageMarket Perform$230.00+13.99%
7/31/2020UBS Group
Boost Price TargetNeutral$202.00 ➝ $215.00+12.77%
5/1/2020Cfra
Lower Price TargetStrong-Buy$234.00 ➝ $231.00+28.18%
5/1/2020Stifel Nicolaus
Boost Price TargetBuy$145.00 ➝ $205.00+9.96%
4/1/2020The Goldman Sachs Group
DowngradeBuy ➝ Sell$248.00 ➝ $150.00-9.90%
1/29/2020Cantor Fitzgerald
C. Bijou
Reiterated RatingNeutral
1/7/2020SunTrust Banks
Initiated CoverageHold$217.00+3.52%
1/7/2020Piper Jaffray Companies
Matthew O'Brien
DowngradeOverweight ➝ Neutral$210.00-1.05%
10/30/2019Bank of America
Boost Price TargetBuy$220.00 ➝ $245.00+11.10%
7/26/2019Royal Bank of Canada
Brandon Henry
Set Price TargetBuy$220.00+2.59%
7/26/2019BMO Capital Markets
Joanne Wuensch
Set Price TargetHold$216.00+0.72%
(Data available from 11/30/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Stryker (NYSE:SYK) Analyst Ratings Frequently Asked Questions

What is Stryker's consensus rating and price target?

According to the issued ratings of 22 analysts in the last year, the consensus rating for Stryker stock is Buy based on the current 1 sell rating, 7 hold ratings and 14 buy ratings for SYK. The average twelve-month price target for Stryker is $288.80 with a high price target of $320.00 and a low price target of $252.00. Learn more on SYK's analyst rating history

Do Wall Street analysts like Stryker more than its competitors?

Analysts like Stryker stock less than the stock of other Medical companies. The consensus rating score for Stryker is 2.59 while the average consensus rating score for medical companies is 2.72. Learn more on how SYK compares to other companies

Do MarketBeat users like Stryker more than its competitors?

MarketBeat users like Stryker stock more than the stock of other Medical companies. 67.83% of MarketBeat users gave Stryker an outperform vote while medical companies recieve an average of 67.43% outperform votes by MarketBeat users.

Does Stryker's stock price have much upside?

According to analysts, Stryker's stock has a predicted upside of 9.53% based on their 12-month price targets.

What analysts cover Stryker?

Stryker has been rated by Morgan Stanley, Piper Sandler, Raymond James, Robert W. Baird, and SVB Leerink in the past 90 days.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.